Why Autoimmune Disease Affects Women More Often Than Men -Hormonal, Chromosomal, and Immunologic Mechanisms — and What the Evidence Does and Does Not Support

Yoon Hang Kim, MD, MPH

Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician

A Real Disparity — Frequently Overstated

Across the autoimmune disease spectrum, women are affected more often than men. That much is not in dispute. What is far less settled is the size of the gap, and this is where much popular writing on the subject goes wrong.

The most widely repeated figure — that 78 to 80% of people with autoimmune disease are women — traces to work published by Fairweather and Rose in 2004. More recent reanalysis by the same research group revised the estimate downward to roughly 67%. Both numbers circulate today, often without acknowledgment that they describe the same underlying question with a decade of methodological refinement in between. A defensible statement is that women account for somewhere between about two-thirds and four-fifths of autoimmune diagnoses, and that the precise figure depends heavily on which conditions are counted and how cases are ascertained.

Disease-specific ratios show the same pattern of drift. Systemic lupus erythematosus is consistently reported at roughly 9:1, and that figure holds up well across cohorts and decades. Others do not. Sjögren's disease is variously reported anywhere from 6:1 to 16:1; a Mayo Clinic cohort of 13,849 patients found 6.4:1, while a figure of 19:1 has circulated in press coverage of recent research. Rheumatoid arthritis and multiple sclerosis are commonly described as 3:1, but registry-based estimates place them closer to 2.1:1 and 1.7:1 respectively.

None of this undermines the central observation. It does mean that clinicians and clients encountering a confident single number should ask which study it came from.

Sex Hormones: Estrogen Amplifies, Androgens Restrain

The oldest explanation involves sex steroid hormones. Estrogens broadly amplify immune activity — supporting B-cell survival, promoting antibody production, and heightening inflammatory signaling. That amplification helps clear infections and supports pregnancy, but it also increases the probability that immune activity will eventually be directed at self.

Androgens work in the opposite direction, and here the mechanism is unusually well characterized. Wilhelmson and colleagues demonstrated that testosterone suppresses B-cell activating factor (BAFF), a cytokine that B cells depend on for survival. Male mice lacking the androgen receptor showed increased splenic B-cell numbers and elevated serum BAFF; among 160 healthy men, those with lower testosterone had measurably higher BAFF levels. Klinefelter syndrome (47,XXY), which combines an additional X chromosome with androgen deficiency, carries a substantially elevated risk of lupus — evidence that both chromosome dosage and hormonal milieu contribute.

A note on the pregnancy narrative. It is often stated flatly that lupus worsens during pregnancy. The evidence is more contested than that phrasing suggests. Reported flare rates across studies range from 13% to 74%. The prospective multicenter PROMISSE study, which followed 384 pregnancies in patients with inactive or stable disease at conception, found that 20.8% experienced mild-to-moderate flares and 6.25% severe flares — with mild flares rarely requiring treatment. The reasonable summary is that pregnancy is a period of altered risk requiring closer monitoring, and that disease activity at conception is a strong predictor of what follows. Rheumatoid arthritis, by contrast, more often improves during gestation.

The X Chromosome and Xist

For decades the XX genotype was known to correlate with autoimmune risk without a clear mechanism. A 2024 study led by Howard Chang's group at Stanford, published in Cell, proposed one centered on Xist — the long noncoding RNA that female cells use to silence one of their two X chromosomes.

To accomplish X-inactivation, Xist assembles with more than 80 binding proteins into a large ribonucleoprotein (RNP) complex. Several of these proteins were already known autoantigens. The investigators engineered male mice to express a non-silencing form of Xist; those mice produced autoantibodies, and in an autoimmune-prone strain they developed more severe multi-organ pathology than wild-type males in a chemically induced lupus model. Separately, antigen arrays showed that serum from patients with autoimmune disease reacted against multiple components of the XIST RNP.

Two details matter for interpreting this correctly. First, Xist expression alone was not sufficient to produce full disease — a tissue-damaging trigger (pristane injection) was also required, consistent with a two-hit model in which chromosomal susceptibility needs an environmental insult to become clinical disease. Second, the causal experiments were performed in mice. The human data are serologic associations, not demonstrations of causation. Subsequent work has begun mapping autoantibody 'hotspots' along the XIST molecule and has linked anti-XIST RNP antibodies to systemic sclerosis, but this remains an active research area rather than settled clinical knowledge.

Baseline Immune Differences

Independent of hormones and chromosomes, women mount stronger immune responses on average. Basal immunoglobulin levels and antibody responses to vaccination and infection are consistently higher in women than men, and men show lower CD3+ and CD4+ counts and lower CD4:CD8 ratios. This heightened responsiveness confers real advantages against infection — one plausible evolutionary rationale, argued by Kronzer and colleagues, is that enhanced maternal antibody production protected offspring during the vulnerable infant period. The same vigilance raises the cumulative probability of self-directed immune activity over a lifetime.

Additional Contributors

• Microchimerism — fetal cells persisting in maternal tissue after pregnancy may act as chronic low-grade antigenic stimuli. Evidence here is more mixed than for hormonal or X-linked mechanisms.
• Gut microbiome differences — sex-specific microbial communities interact with hormone signaling to influence autoimmune susceptibility, demonstrated most clearly in animal models.
• Environmental and epigenetic factors — UV exposure, occupational and cosmetic chemical exposures, and epigenetic modification layer onto these substrates to determine who becomes symptomatic.

Reported Sex Ratios by Condition

The table below separates registry-anchored estimates from the wider range found across the literature, so that the spread is visible rather than hidden behind a single number.

Ankylosing spondylitis is included deliberately. The female bias in autoimmunity is a strong tendency, not a rule — several conditions, including type 1 diabetes, Crohn's disease, and myocarditis, are more common in men. Any single unified mechanism would have to explain these exceptions as well.

Strength of the Evidence

Readers should weigh the following limitations when interpreting this material:

• Much of the mechanistic work is preclinical. The authors of the most comprehensive recent review state directly that the key factors have been identified mainly in animal models and cell culture experiments.
• Prevalence figures are methodologically sensitive. Estimates shift depending on case ascertainment, diagnostic criteria, healthcare access, and whether data come from specialty clinics or population registries. Clinic-based cohorts tend to overstate female predominance.
• Press coverage amplifies outlier figures. Ratios cited in institutional press releases and health journalism are sometimes drawn from the high end of the published range without that context.
• Correlation and causation remain distinct. Higher antibody levels are strongly associated with autoimmunity in women, but whether they are a cause, a consequence, or a parallel phenomenon is not resolved.

Clinical Implications

Sex-aware care follows reasonably from this evidence base. It includes anticipating changes in disease activity around pregnancy, the postpartum period, and perimenopause; recognizing that men with female-predominant conditions may face diagnostic delay precisely because those conditions are considered uncommon in men; and treating hormonal status and reproductive history as relevant clinical data rather than background detail.

The Xist RNP and androgen/BAFF pathways are worth following as they mature. Neither currently supports a clinical intervention, and it would be premature to describe either as actionable.

Learn more about integrative and functional medicine approaches to autoimmune conditions at www.directintegrativecare.com.

References

1. Fairweather D, Beetler DJ, McCabe EJ, Lieberman SM. Mechanisms underlying sex differences in autoimmunity. J Clin Invest. 2024;134(18):e180076. doi:10.1172/JCI180076. PMID: 39286970.

2. Dou DR, Zhao Y, Belk JA, et al. Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell. 2024;187(3):733-749.e16. doi:10.1016/j.cell.2023.12.037. PMID: 38306984.

3. Wilhelmson AS, Lantero Rodriguez M, Stubelius A, et al. Testosterone is an endogenous regulator of BAFF and splenic B cell number. Nat Commun. 2018;9:2067. doi:10.1038/s41467-018-04408-0.

4. Kronzer VL, Bridges SL Jr, Davis JM III. Why women have more autoimmune diseases than men: an evolutionary perspective. Evol Appl. 2021;14(3):629-633. doi:10.1111/eva.13167. PMID: 33767739.

5. Bose M, Jefferies C. Sex bias in systemic lupus erythematosus: a molecular insight. Immunometabolism. 2022;4(3):e00004. doi:10.1097/IN9.0000000000000004.

6. Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect Dis. 2004;10(11):2005-2011. doi:10.3201/eid1011.040367. PMID: 15550215.

7. Scofield RH, Bruner GR, Namjou B, et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum. 2008;58(8):2511-2517. doi:10.1002/art.23701. PMID: 18668569.

8. Brandt JE, Priori R, Valesini G, Fairweather D. Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ. 2015;6:19. doi:10.1186/s13293-015-0037-7.

9. Davis-Porada J, Kim MY, Guerra MM, et al. Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther. 2020;22:52. doi:10.1186/s13075-020-2139-9. PMID: 32188491.

10. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626-638. doi:10.1038/nri.2016.90.

11. Yan B, Lee J, Srinivasan S, et al. Autoantibody hotspots reveal the origin and impact of immunogenic XIST ribonucleoprotein complexes in autoimmune diseases. J Clin Invest. 2026. doi:10.1172/JCI198291. PMID: 41665934.